Raymond James & Associates’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.51M | Buy |
+55,204
| New | +$1.51M | ﹤0.01% | 2409 |
|
|
2021
Q4 | – | Sell |
-9,542
| Closed | -$308K | – | 4044 |
|
|
2021
Q3 | $308K | Sell |
9,542
-52
| -0.5% | -$1.68K | ﹤0.01% | 3374 |
|
|
2021
Q2 | $293K | Buy |
+9,594
| New | +$293K | ﹤0.01% | 3426 |
|
|
2020
Q2 | – | Sell |
-18,155
| Closed | -$260K | – | 3478 |
|
|
2020
Q1 | $260K | Buy |
18,155
+3,049
| +20% | +$43.7K | ﹤0.01% | 2852 |
|
|
2019
Q4 | $411K | Buy |
+15,106
| New | +$411K | ﹤0.01% | 2859 |
|
|
2019
Q2 | – | Sell |
-9,493
| Closed | -$315K | – | 3575 |
|
|
2019
Q1 | $315K | Buy |
9,493
+1,923
| +25% | +$63.8K | ﹤0.01% | 2943 |
|
|
2018
Q4 | $220K | Buy |
7,570
+651
| +9% | +$18.9K | ﹤0.01% | 3053 |
|
|
2018
Q3 | $318K | Buy |
+6,919
| New | +$318K | ﹤0.01% | 2969 |
|
|
2018
Q1 | – | Sell |
-6,331
| Closed | -$217K | – | 3410 |
|
|
2017
Q4 | $217K | Sell |
6,331
-2,766
| -30% | -$94.8K | ﹤0.01% | 2988 |
|
|
2017
Q3 | $329K | Buy |
+9,097
| New | +$329K | ﹤0.01% | 2718 |
|
|
2015
Q1 | – | Sell |
-10,173
| Closed | -$346K | – | 2366 |
|
|
2014
Q4 | $346K | Buy |
10,173
+66
| +0.7% | +$2.25K | ﹤0.01% | 2067 |
|
|
2014
Q3 | $390K | Sell |
10,107
-19,425
| -66% | -$750K | ﹤0.01% | 1936 |
|
|
2014
Q2 | $1.15M | Buy |
+29,532
| New | +$1.15M | 0.01% | 1410 |
|
|
2013
Q3 | – | Sell |
-17,552
| Closed | -$472K | – | 1942 |
|
|
2013
Q2 | $472K | Buy |
+17,552
| New | +$472K | ﹤0.01% | 1534 |
|